Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Imatinib in COVID-19: hope and caution.
Bernal-Bello D, Morales-Ortega A, Isabel Farfán-Sedano A, de Tena JG, Martín-López JVS. Bernal-Bello D, et al. Lancet Respir Med. 2021 Sep;9(9):938-939. doi: 10.1016/S2213-2600(21)00266-6. Epub 2021 Jun 18. Lancet Respir Med. 2021. PMID: 34147143 Free PMC article. No abstract available.
Vitamin D status and ill health.
de Tena JG, Abejón-López L, Hernández-Gutiérrez C, Bernal-Bello D, Rodríguez-Zapata M. de Tena JG, et al. Lancet Diabetes Endocrinol. 2014 Apr;2(4):e9-e10. doi: 10.1016/S2213-8587(14)70046-4. Lancet Diabetes Endocrinol. 2014. PMID: 24703058 No abstract available.
Novel risk factors related to cancer in scleroderma.
Bernal-Bello D, de Tena JG, Guillén-Del Castillo A, Selva-O'Callaghan A, Callejas-Moraga EL, Marín-Sánchez AM, Fonollosa-Pla V, Simeón-Aznar CP. Bernal-Bello D, et al. Autoimmun Rev. 2017 May;16(5):461-468. doi: 10.1016/j.autrev.2017.03.012. Epub 2017 Mar 8. Autoimmun Rev. 2017. PMID: 28285170 Review.
Imatinib might constitute a treatment option for lung involvement in COVID-19.
Bernal-Bello D, Jaenes-Barrios B, Morales-Ortega A, Ruiz-Giardin JM, García-Bermúdez V, Frutos-Pérez B, Farfán-Sedano AI, de Ancos-Aracil C, Bermejo F, García-Gil M, Zapatero-Gaviria A, San Martín-López JV. Bernal-Bello D, et al. Autoimmun Rev. 2020 Jul;19(7):102565. doi: 10.1016/j.autrev.2020.102565. Epub 2020 May 3. Autoimmun Rev. 2020. PMID: 32376403 Free PMC article. No abstract available.
Imatinib for COVID-19: A case report.
Morales-Ortega A, Bernal-Bello D, Llarena-Barroso C, Frutos-Pérez B, Duarte-Millán MÁ, García de Viedma-García V, Farfán-Sedano AI, Canalejo-Castrillero E, Ruiz-Giardín JM, Ruiz-Ruiz J, San Martín-López JV. Morales-Ortega A, et al. Clin Immunol. 2020 Sep;218:108518. doi: 10.1016/j.clim.2020.108518. Epub 2020 Jun 27. Clin Immunol. 2020. PMID: 32599278 Free PMC article. No abstract available.
Early clinical experience with imatinib in COVID-19: Searching for a dual effect.
Morales-Ortega A, Rivas-Prado L, Frutos-Pérez B, Jaenes-Barrios B, Farfán-Sedano AI, García-Parra CJ, Hernández-Muniesa B, Duarte-Millán MÁ, Madroñal-Cerezo E, Ontañón-Nasarre A, Ruiz-Giardín JM, Bermejo F, García-Gil M, Gonzalo-Pascua S, San Martín-López JV, Bernal-Bello D. Morales-Ortega A, et al. J Infect. 2021 May;82(5):186-230. doi: 10.1016/j.jinf.2021.02.002. Epub 2021 Feb 5. J Infect. 2021. PMID: 33549625 Free PMC article.
Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients.
Morales-Ortega A, Farfán-Sedano AI, Izquierdo-Martínez A, Llarena-Barroso C, Jaenes-Barrios B, Mesa-Plaza N, Toledano-Macías M, Soria Fernández-Llamazares G, Molina-Esteban L, García de Tena J, Prieto-Menchero S, Gonzalo-Pascua S, San Martín-López JV, Bernal-Bello D. Morales-Ortega A, et al. J Infect. 2022 Feb;84(2):248-288. doi: 10.1016/j.jinf.2021.08.034. Epub 2021 Aug 23. J Infect. 2022. PMID: 34437930 Free PMC article. No abstract available.
42 results